Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Medical System Joins PRC’s Drug Distribution Rollup

publication date: Apr 5, 2011
China Medical System Holdings will pay almost $200 million to acquire Tianjin Precede Medical Trade Development Co., a fellow drug distributor in China. CMS said the transaction will give it new products to sell and a larger sales network. Like other PRC drug distribution companies, CMS is following the well-trodden path of IPOing on the Hong Kong exchange and using the proceeds to continue the steady rollup of China’s pharma distribution networks. More details....

Stock Symbol: (HK: 867)     Share this with colleagues:  


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital